Amneal Pharmaceuticals Stock Quote AMRX - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

8.41

Bid

8.25

Ask

13.45

Volume

150

0.00 Day's Range 0.00

5.01 52 Week Range 9.475

Market Cap

2.606B

Previous Close

8.41

Open

Last Trade

150

8.41

(formt)

Last Trade Time

04:31:15

Financial Volume

VWAP

Average Volume (3m)

1,084,639

Shares Outstanding

309,844,430

Dividend Yield

PE Ratio

-21.65

Earnings Per Share (EPS)

-0.27

Revenue

2.41B

Net Profit

-83.99M

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inha... Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.amneal.com

Headquarters

Wilmington, Delaware, USA

Founded

Amneal Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AMRX. The last closing price for Amneal Pharmaceuticals was $8.41. Over the last year, Amneal Pharmaceuticals shares have traded in a share price range of $ 5.01 to $ 9.475.

Amneal Pharmaceuticals currently has 309,844,430 shares outstanding. The market capitalization of Amneal Pharmaceuticals is $2.61 billion. Amneal Pharmaceuticals has a price to earnings ratio (PE ratio) of -21.65.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.75	-8.18777292576	9.16	9.25	8.11	1105166	8.55906855	CS
4	0.005	0.0594883997621	8.405	9.475	7.52	1140134	8.65827459	CS
12	-0.22	-2.54924681344	8.63	9.475	7.52	1084639	8.5929668	CS
26	1.74	26.0869565217	6.67	9.475	6.29	1288364	7.69668493	CS
52	2.53	43.0272108844	5.88	9.475	5.01	1392108	6.80269207	CS
156	2.53	43.0272108844	5.88	9.475	5.01	1392108	6.80269207	CS
260	2.53	43.0272108844	5.88	9.475	5.01	1392108	6.80269207	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WORXSCWorx Corporation	$ 1.98 (102.04%)	16.34M
AKTSAkoustis Technologies Inc	$ 0.1321 (51.66%)	57.77M
PETWag Group Company	$ 0.303 (44.22%)	18.31M
ESGROEnstar Group Ltd	$ 28.00 (40.92%)	28
CCECCapital Clean Energy Carriers Corporation	$ 24.99 (34.72%)	11
WSBFWaterstone Financial Inc	$ 9.00 (-40.98%)	4
TRSTriMas Corporation	$ 15.62 (-40.79%)	3
BCAXBicara Therapeutics Inc	$ 11.00 (-40.15%)	212
PYXSPyxis Oncology Inc	$ 2.43 (-36.39%)	209.56k
XNCRXencor Inc	$ 15.11 (-36.30%)	2
AKTSAkoustis Technologies Inc	$ 0.1321 (51.66%)	57.77M
PETWag Group Company	$ 0.303 (44.22%)	18.31M
WORXSCWorx Corporation	$ 1.98 (102.04%)	16.34M
XTKGX3 Holdings Company Ltd	$ 0.0775 (-13.89%)	10.83M
CRKNCrown Electrokinetics Corporation	$ 0.9853 (25.41%)	5.59M